Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FQ1CH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,080
Award facts
- Contract value 100% obligated
- $14,079.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pen injections with a ceiling value of $14,079.71. This is a firm fixed price delivery order with an ultimate completion date of June 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Wegovy, a GLP-1 receptor agonist commonly used for weight management, supports the Defense Health Agency's pharmaceutical supply needs for military personnel and beneficiaries.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly through its comprehensive $999.999 billion DLA Troop Support Medical contract running through December 2026. This broader contract vehicle enables the company to supply an extensive range of pharmaceuticals, specialty medications, vaccines, and medical devices to support military healthcare programs globally. The company's role as a prime pharmaceutical vendor underscores its established capability to fulfill federal procurement requirements efficiently and competitively across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQ1CH?
SPE2DB25FQ1CH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FQ1CH worth?
The government has obligated $14,080 on SPE2DB25FQ1CH.
Is contract SPE2DB25FQ1CH an order under another contract?
Yes. SPE2DB25FQ1CH is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1CH competed?
The extent of competition for SPE2DB25FQ1CH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award